EDGE study in Russian Federation: efficacy and safety of vildagliptine in comparison with other oral antidiabetic agents in patients with type 2 diabetes mellitus
According to international consensus, metformin is acknowledged as a first-line therapeutic agent for type 2 diabetes mellitus (T2DM). However, in most cases this treatment eventually requires intensification by supplementation with other hypoglycemic medications. The aim of the EDGE study (Effectiv...
Saved in:
Main Author: | |
---|---|
Format: | article |
Language: | EN RU |
Published: |
Endocrinology Research Centre
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/05a818a1512f45d2a2c1afbc3ea75738 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|